Esteve Pharmaceuticals GmbH
PolandAll drugs from this manufacturer
-
The drug is used in the treatment of primary and secondary hyperaldosteronism (e.g., in the course of severe liver disease with edema or in chronic heart failure with edema). It is also used when the drug cannot be administered orally or when other diuretics do not work sufficiently well.
Dosage form: solution for injection
Active substance Dosage potassium canrenoate 20 mg/ml ATC: C03DA03
-
The drug is used in the treatment of primary and secondary hyperaldosteronism. It may also be used in cases of chronic heart failure with edema, when oral medication cannot be administered or when other diuretics do not work sufficiently well.
Dosage form: solution for injection
Active substance Dosage potassium canrenoate 20 mg/ml ATC: C03DA02